Johnson & Johnson Wins Talc Cancer Lawsuit Involving Three Women
J&J secured a courtroom victory in a talc-related cancer case brought by three plaintiffs, adding to the company's mixed litigation record.
Johnson & Johnson defeated a lawsuit Wednesday alleging that its talc-based products caused cancer in three women, delivering the pharmaceutical and consumer goods giant another courtroom win in a long-running legal battle over the safety of its iconic baby powder and related products.
The verdict offers J&J a measure of relief as the company continues to face thousands of similar claims nationwide linking its talc products to ovarian cancer and mesothelioma. The company has consistently denied that its talc caused any illness, citing decades of safety testing and regulatory reviews that it says support the product's safety profile.
Read more Veeva Systems Acquires Copli, Unveils Falcon MLR Platform →
The outcome is significant in the broader context of J&J's talc litigation strategy. The company has pursued a controversial legal maneuver — attempting to route talc claims through bankruptcy proceedings via a subsidiary — which courts have repeatedly scrutinized and, at times, blocked. Individual trial victories like this one reinforce J&J's argument that juries can and do side with the company when cases are heard on their merits.
For plaintiffs' attorneys and advocacy groups, however, a single defense verdict does little to resolve the wider scientific and legal debate over talc's safety. Thousands of pending cases mean the litigation is far from over, and future juries may reach different conclusions depending on the evidence and expert testimony presented.
Continue reading at Yahoo Finance.
